C. Chimbetete

发表

Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.

M. Egger, F. Dabis, K. Wools-Kaloustian, 2015, The lancet. HIV.

An in-depth statistical analysis of the COVID-19 pandemic’s initial spread in the WHO African region

B. Impouma, O. Keiser, C. Chimbetete, 2022, BMJ Global Health.

Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe

M. Roelens, O. Keiser, C. Chimbetete, 2020, PloS one.

Tenofovir in Second-Line ART in Zambia and South Africa: Collaborative Analysis of Cohort Studies

M. Egger, R. Wood, G. Wandeler, 2012, Journal of acquired immune deficiency syndromes.

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe

D. Katzenstein, M. Egger, A. Spoerri, 2018 .

Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe.

D. Raben, F. Tanser, C. Chimbetete, 2016, International journal of epidemiology.

Comparison of predictors for early and late mortality in adults commencing HIV antiretroviral therapy in Zimbabwe: a retrospective cohort study

C. Chimbetete, D. Drak, D. Gracey, 2022, AIDS Research and Therapy.

Predictors of renal impairment and proteinuria after commencement of antiretroviral therapy in a Zimbabwean HIV cohort

C. Chimbetete, D. Drak, D. Gracey, 2022, HIV medicine.

Body mass index and noninfectious comorbidity in HIV‐positive patients commencing antiretroviral therapy in Zimbabwe

C. Chimbetete, D. Gracey, T. Shamu, 2020, HIV medicine.

The toll of COVID-19 on African children: A descriptive analysis on COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa

A. Talisuna, B. Impouma, O. Keiser, 2021, International Journal of Infectious Diseases.

Cancer incidence among people living with HIV in Zimbabwe: A record linkage study

M. Egger, J. Bohlius, A. Spoerri, 2021, Cancer reports.

Brief Report: Validation of the D:A:D Chronic Kidney Disease Risk Score Incorporating Proteinuria in People Living With HIV in Harare, Zimbabwe

C. Chimbetete, D. Gracey, T. Shamu, 2022, Journal of acquired immune deficiency syndromes.

Outcomes of an HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare, Zimbabwe: TENART cohort

C. Chimbetete, T. Shamu, T. Mudzviti, 2017, PloS one.

Monitoring and Switching of First-line Antiretroviral Therapy in sub-Saharan Africa: Collaborative Analysis of Adult Treatment Cohorts

M. Egger, F. Dabis, G. Wandeler, 2015 .

Factors associated with 1st line ART failure among patients at Newlands Clinic, Harare

C. Chimbetete, 2014 .

Real‐world use and outcomes of dolutegravir‐containing antiretroviral therapy in HIV and tuberculosis co‐infection: a site survey and cohort study in sub‐Saharan Africa

M. Yotebieng, L. Diero, K. Wools-Kaloustian, 2022, Journal of the International AIDS Society.

Tracing people living with HIV who are lost to follow-up at ART programs in Southern Africa: A sampling-based cohort study in six countries.

M. Egger, M. Vinikoor, J. V. van Dijk, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

COVID-19 pandemic in Africa’s island nations during the first 9 months: a descriptive study of variation in patterns of infection, severe disease, and response measures

B. Impouma, O. Keiser, C. Chimbetete, 2022, BMJ Global Health.

Renal function and associated mortality risk in adults commencing HIV antiretroviral therapy in Zimbabwe

C. Chimbetete, D. Drak, D. Gracey, 2021, AIDS.

Profile of elderly patients receiving antiretroviral therapy at Newlands Clinic in 2020: A cross-sectional study

C. Chimbetete, T. Shamu, T. Mudzviti, 2020, Southern African journal of HIV medicine.

Metabolic syndrome among treatment‐naïve people living with and without HIV in Zambia and Zimbabwe: a cross‐sectional analysis

R. Chilengi, G. Wandeler, C. Chimbetete, 2022, Journal of the International AIDS Society.

Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa.

N. Ford, M. Egger, A. Haas, 2019, Journal of acquired immune deficiency syndromes.

Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

Rabie, Helena, Gertrude, 2018 .

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.

M. Zwahlen, M. Egger, B. Eley, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe

C. Chimbetete, T. Shamu, Sandra Shawarira-Bote, 2019, BMC Infectious Diseases.

Inequality in outcomes for adolescents living with perinatally acquired HIV in sub‐Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis

M. Yotebieng, S. Ayaya, R. Sahabo, 2018, Journal of the International AIDS Society.

A Time to Event Analysis of Adverse Drug Reactions Due to Tenofovir, Zidovudine and Stavudine in a Cohort of Patients Receiving Antiretroviral Treatment at an Outpatient Clinic in Zimbabwe

C. Chimbetete, C. Maponga, G. Morse, 2015 .

Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study

C. Chimbetete, M. Pascoe, T. Shamu, 2019, Drugs - Real World Outcomes.

Incidence Rate of Kaposi Sarcoma in HIV-Infected Patients on Antiretroviral Therapy in Southern Africa: A Prospective Multicohort Study

B. Chi, M. Egger, D. Dickinson, 2014, Journal of acquired immune deficiency syndromes.

Authors' Reply: Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go.

B. Chi, M. Egger, K. Wools-Kaloustian, 2015, Journal of acquired immune deficiency syndromes.

Effect of antiretroviral therapy care interruptions on mortality in children living with HIV

F. Tanser, B. Eley, M. Vinikoor, 2022, AIDS.

High Unreported Mortality in Children and Youth (<25 Years) Living With HIV Who Were Lost to Care From Antiretroviral Therapy Programs in Southern Africa: Results From a Multicountry Tracing Study

C. Yiannoutsos, M. Egger, M. Vinikoor, 2022, Journal of acquired immune deficiency syndromes.

Immunodeficiency in Children Starting Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, M. Egger, K. Wools-Kaloustian, 2015, Journal of acquired immune deficiency syndromes.

Prognosis of Children With HIV-1 Infection Starting Antiretroviral Therapy in Southern Africa: A Collaborative Analysis of Treatment Programs

M. Egger, B. Eley, R. Wood, 2014, The Pediatric infectious disease journal.

When to Start Antiretroviral Therapy in Children Aged 2–5 Years: A Collaborative Causal Modelling Analysis of Cohort Studies from Southern Africa

M. Egger, L. Muhe, B. Eley, 2013, PLoS medicine.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, Lancet.

Models of support for disclosure of HIV status to HIV‐infected children and adolescents in resource‐limited settings

S. Ayaya, C. Chimbetete, M. Davies, 2018, Journal of the International AIDS Society.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age.

A. Sohn, V. Rouzier, R. Succi, 2021, The Pediatric Infectious Disease Journal.

A survey of paediatric HIV programmatic and clinical management practices in Asia and sub-Saharan Africa—the International epidemiologic Databases to Evaluate AIDS (IeDEA)

J. Ananworanich, F. Dabis, B. Eley, 2013, Journal of the International AIDS Society.

Tracing people living with HIV who are lost to follow-up at ART programs in Southern Africa: Study protocol

M. Egger, M. Vinikoor, J. V. van Dijk, 2020 .

Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa.

B. Eley, A. Sohn, C. Chimbetete, 2020, AIDS.

A case report of untreatable HIV infection in Harare, Zimbabwe

O. Keiser, C. Chimbetete, M. Pascoe, 2019, Southern African journal of HIV medicine.

Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study

M. Egger, C. Chimbetete, T. Shamu, 2021, PloS one.

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes

O. Keiser, C. Chimbetete, T. Shamu, 2020, PloS one.

Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, J. Sterne, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Assessing renal impairment in treatment-naïve adolescents living with HIV commencing antiretroviral therapy in Zimbabwe

C. Chimbetete, D. Drak, D. Gracey, 2023, AIDS.

Baseline renal function predicts mortality in adolescents commenced on HIV antiretroviral therapy.

C. Chimbetete, D. Drak, D. Gracey, 2021, AIDS.

Sexually transmitted infections, the silent partner in HIV-infected women in Zimbabwe

C. Chimbetete, M. Pascoe, T. Shamu, 2019, Southern African journal of HIV medicine.

HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing.

C. Chimbetete, D. Katzenstein, T. Shamu, 2017, Journal of virological methods.

Leveraging human resources for outbreak analysis: lessons from an international collaboration to support the sub-Saharan African COVID-19 response

Adit V. Kaneria, M. Roelens, B. Impouma, 2022, BMC Public Health.

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa.

T. F. Rinke de Wit, C. Chimbetete, K. Mandaliya, 2016, The Journal of infectious diseases.

Seasonal variations in tuberculosis diagnosis among HIV-positive individuals in Southern Africa: analysis of cohort studies at antiretroviral treatment programmes

M. Zwahlen, M. Egger, C. Chimbetete, 2018, BMJ Open.

Characterizing the double‐sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa

A. Sohn, C. Chimbetete, M. Davies, 2020, Journal of the International AIDS Society.

Drug Resistance among Adolescents and Young Adults with Virologic Failure of First Line ART and Response to Second Line Treatment.

C. Chimbetete, T. Shamu, T. Mudzviti, 2020, AIDS research and human retroviruses.

Immunological response to boosted PI-containing second line ART after switching for clinical/immunological criteria is comparable to response to first-line in patients with low CD4 counts in Africa.

C. Gilks, J. Darbyshire, C. Chimbetete, 2008 .

Cervical Cancer Screening Cascade for women living with HIV: A cohort study from Zimbabwe

M. Egger, T. Magure, J. Bohlius, 2021, PLOS global public health.

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.

New‐onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysis

M. Egger, B. Kalesan, O. Keiser, 2017, Tropical medicine & international health : TM & IH.

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

D. Pillay, J. Kigozi, E. Katabira, 2014, The Journal of antimicrobial chemotherapy.

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe

D. Katzenstein, M. Egger, A. Spoerri, 2018, Open forum infectious diseases.

Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium

L. Diero, F. Dabis, F. Palella, 2022, Journal of the International AIDS Society.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, The Lancet.

Body weight and blood pressure changes on dolutegravir‐, efavirenz‐ or atazanavir‐based antiretroviral therapy in Zimbabwe: a longitudinal study

C. Chimbetete, N. Anderegg, T. Shamu, 2024, Journal of the International AIDS Society.

Incidence and risk factors of anaemia among people on antiretroviral therapy in Harare

Chérie E. Part, C. Chimbetete, T. Shamu, 2024, Southern African journal of HIV medicine.